Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Alvine Pharmaceuticals Inc.

ClinicalTrials.gov Identifier:

NCT01255696

First received: December 3, 2010

Last updated: July 30, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2011
Primary Completion Date:	May 2011 (Final data collection date for primary outcome measure)
Certification or Request for Extension to Delay Results Received:	July 13, 2012